The influence of cell growth media on the stability and antitumour activity of methionine enkephalin

Journal of Peptide Science

Volumn 11, Issue 8, 2005, Pages 506-511

  Glavaš Obrovac, Ljubica ^a   Jakas, Andreja ^b   Marczi, Saška ^a   Horvat, Štefica ^b  

^a UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Bestatin; Captopril; Cytotoxicity in vitro; DMEM; Fetal bovine serum; Methionine enkephalin; Protease inhibitors; Thiorphan

Indexed keywords

BESTATIN; CAPTOPRIL; METENKEPHALIN; THIORPHAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DEGRADATION KINETICS; DRUG HYDROLYSIS; DRUG STABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CULTURE MEDIA; DRUG SCREENING ASSAYS, ANTITUMOR; ENKEPHALIN, METHIONINE; HUMANS; TUMOR CELLS, CULTURED;

BOVINAE;

EID: 23144457061     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.643     Document Type: Article

References (22)

1. Lien S, Lowman HB. Therapeutic peptides. Trends Biotechnol. 2003; 21: 556-562.
2. Loffet A. Peptides as drugs: Is there a market? J. Peptide Sci. 2002: 8: 1-7.
3. Janin YL. Peptides with anticancer use or potential. Amino Acids 2003; 25: 1-40.
4. Andersson E, Rydengard V, Sonesson A, Morgelin M, Bjorck L, Schmidtchen A. Antimicrobial activities of heparin-binding peptides. Eur. J. Biochem. 2004; 271: 1219-1226.
5. Adessi C, Frossard MJ, Boissard C, Fraga S, Bieler S, Ruckle T, Vilbois F, Robinson SM, Mutter M, Banks WA, Soto C. Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. J. Biol. Chem. 2003; 278: 13 905-13 911.
6. Soto C, Kascsak RJ, Saborio GP, Aucouturier P, Wisniewski T, Prelli F, Kascsak R, Mendez E, Harris DA, Ironside J, Tagliavini F, Carp RI, Frangione B. Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides. Lancet 2000; 355: 192-197.
7. Li F, Dluzewski A, Coley AM, Thomas A, Tilley L, Anders RF, Foley M. Phage-displayed peptides bind to the malarial protein apical membrane antigen-1 and inhibit the merozoite invasion of host erythrocytes. J. Biol. Chem. 2002; 277: 50 303-50 310.
8. Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 2003; 24: 389-427.
9. Sehgal A. Recent developments in peptide-based cancer therapeutics. Curr. Opin. Drug Discov. Develop. 2002; 5: 245-250.
10. Zoli W, Ricotti L, Tesei A, Barzanti F, Amadori D. In vitro preclinical models for a rational design of chemotherapy combinations in human tumors. Crit. Rev. Oncol./Hematol. 2001; 37: 69-82.
11. Xu JM, Song ST, Tang ZM, Jiang ZF, Liu XQ, Zhou L, Zhang J, Liu XW. Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro. Breast Cancer Res. Treat. 1999; 53: 77-85.
12. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl Cancer Inst. 1990; 82: 1107-1112.
13. Stein C, Schafer M, Machelska H. Attacking pain at its source: new perspectives on opioids. Nature Med. 2003; 9: 1003-1008.
14. Bodnar RJ, Hadjimarkou MM. Endogenous opiates and behaviour: 2002. Peptides 2003; 24: 1241-1302.
15. Plotnikoff NP, Faith RE, Murgo AJ, Herberman RB, Good RA. Methionine enkephalin: a new cytokine. Human studies. Clin. Immunol. Immunopathol. 1997; 82: 93-101.
16. Zagon IS, Verderame MF, McLaughlin PJ. The biology of the opioid growth factor receptor (OGFr). Brain Res. Rev. 2002; 38: 351-376.
17. Horiuchi N, Nagawa K, Sasaky Y, Minato K, Fujiwara Y, Nezu K, Ohe Y, Sajo N. In vitro antitumor activity of mitomycin C derivative (RM-49) and a new anticancer antibiotic (FK 973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay. Cancer Chemother. Pharmacol. 1988; 22: 246-250.
18. Hambrook JM, Morgan BA, Rance MJ, Smith CFC. Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature 1976; 262: 782-783.
19. Agu RU, Dang HV, Jorissen M, Kinget R, Verbeke N. Metabolism and absorption enhancement of methionine enkephalin in human nasal epithelium. Peptides 2004; 25: 563-569.
20. Van der Valk J, Mellor D, Brands R, Fischer R, Gruber F, Gstraunthaler G, Hellebrekers L, Hyllner J, Jonker FH, Prieto P, Thalen M, Baumans V. The human collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol. In Vitro 2004; 18: 1-12.
21. Sekine K, Fujii H, Abe F, Nishikawa K. Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines. Int. J. Cancer 2001; 94: 485-491.
22. Kehlen A, Göhring B, Langner J, Riemann D. Regulation of expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators. Clin. Exp. Immunol. 1998; 111: 435-441.